Summary
The prevalence of Parkinson’s disease, the second most common neurodegenerative disorder, is increasing worldwide. Characterised clinically by progressive asymmetric slowness of movement, rigidity, tremor, gait disturbance, and a wide range of non-motor symptoms, the aetiology of Parkinson’s disease is multifactorial, involving both genetic and environmental risk factors. Despite the growing public health burden, current treatment strategies are focused solely on symptom management—and disease-modifying treatments are urgently needed to help prevent development of the most disabling refractory symptoms, such as gait and balance difficulties, cognitive impairment and dementia, and speech and swallowing problems.
In this three-paper Series, the authors address the current state of knowledge on the epidemiology of Parkinson’s disease, recent advances in our understanding of the pathogenesis of the disease, as well as the latest evidence supporting the optimal medical, surgical, and physical treatment of Parkinson’s disease.
0 Comments
Recommended Comments
There are no comments to display.
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now